DECLARATION OF INTERESTS
No conflict of interest for none of the authors.
REFERENCES
1. Modrow S, Falke, D., Truyen, U., & Schätzl, H. Viruses with
Single-Stranded, Positive-Sense RNA Genomes. Molecular Virology .
Aug 12. Berlin Heidelberg: Springer-Verlag; 2013. p. 185-349
2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic
characterisation and epidemiology of 2019 novel coronavirus:
implications for virus origins and receptor binding. Lancet.
2020;395(10224):565-74.
3. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the
Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a
Report of 72 314 Cases From the Chinese Center for Disease Control and
Prevention. Jama. 2020.
4. Coronavirus disease 2019 (COVID-19) situation report – 130.
[Internet]. 2020. Available from:
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200529-covid-19-sitrep-130.pdf?sfvrsn=bf7e7f0c_4.
5. Li X, Guan B, Su T, Liu W, Chen M, Bin Waleed K, et al. Impact of
cardiovascular disease and cardiac injury on in-hospital mortality in
patients with COVID-19: a systematic review and meta-analysis. Heart.
2020.
6. Targher G, Mantovani A, Wang XB, Yan HD, Sun QF, Pan KH, et al.
Patients with diabetes are at higher risk for severe illness from
COVID-19. Diabetes Metab. 2020.
7. Paul WE. Fundamental immunology. 7th ed. Philadelphia: Wolters Kluwer
Health/Lippincott Williams & Wilkins; 2013. xviii, 1283 p. p.
8. Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, et al. Adaptive immune
cells temper initial innate responses. Nat Med. 2007;13(10):1248-52.
9. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et
al. COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020;395(10229):1033-4.
10. Ulhaq ZS, Soraya GV. Interleukin-6 as a potential biomarker of
COVID-19 progression. Med Mal Infect. 2020;50(4):382-3.
11. Chen IY, Moriyama M, Chang MF, Ichinohe T. Severe Acute Respiratory
Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome.
Front Microbiol. 2019;10:50.
12. Park A, Iwasaki A. Type I and Type III Interferons - Induction,
Signaling, Evasion, and Application to Combat COVID-19. Cell Host
Microbe. 2020.
13. Yan X, Li F, Wang X, Yan J, Zhu F, Tang S, et al. Neutrophil to
Lymphocyte Ratio as Prognostic and Predictive Factor in Patients with
Coronavirus Disease 2019: A Retrospective Cross-sectional Study. J Med
Virol. 2020.
14. Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, et al. [Analysis of
clinical features of 29 patients with 2019 novel coronavirus
pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0):E005.
15. Wang F, Hou H, Luo Y, Tang G, Wu S, Huang M, et al. The laboratory
tests and host immunity of COVID-19 patients with different severity of
illness. JCI Insight. 2020;5(10).
16. Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. [A
pathological report of three COVID-19 cases by minimal invasive
autopsies]. Zhonghua Bing Li Xue Za Zhi. 2020;49(5):411-7.
17. Li S, Jiang L, Li X, Lin F, Wang Y, Li B, et al. Clinical and
pathological investigation of severe COVID-19 patients. JCI Insight.
2020.
18. van Erp EA, van Kampen MR, van Kasteren PB, de Wit J. Viral
Infection of Human Natural Killer Cells. Viruses. 2019;11(3).
19. Meraviglia S, El Daker S, Dieli F, Martini F, Martino A. γδ T cells
cross-link innate and adaptive immunity in Mycobacterium tuberculosis
infection. Clin Dev Immunol. 2011;2011:587315.
20. Gianchecchi E, Delfino DV, Fierabracci A. NK cells in autoimmune
diseases: Linking innate and adaptive immune responses. Autoimmun Rev.
2018;17(2):142-54.
21. Voelkl S, Gary R, Mackensen A. Characterization of the
immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T
cells. Eur J Immunol. 2011;41(3):739-48.
22. Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D, et al. Human CD8. BMC
Immunol. 2020;21(1):23.
23. Tulunay A. Regulation of CD8+ Suppressor T cells with Pattern
Recognition
Receptors http://dspace.marmara.edu.tr/handle/11424/20297?locale-attribute=tr:
Marmara University; 2011.
24. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al.
A SARS-CoV-2 protein interaction map reveals targets for drug
repurposing. Nature. 2020.
25. Rodriguez F, Novak I. What-about-the-neutrophils-phenotypes. Hematol
Med Oncol 2 [Internet]. 2017; 2(3):[1-6
pp.]. Available from:
https://www.oatext.com/What-about-the-neutrophils-phenotypes.php#Article_Info.
26. Shipp MA, Stefano GB, Switzer SN, Griffin JD, Reinherz EL. CD10
(CALLA)/neutral endopeptidase 24.11 modulates inflammatory
peptide-induced changes in neutrophil morphology, migration, and
adhesion proteins and is itself regulated by neutrophil activation.
Blood. 1991;78(7):1834-41.
27. Marini O, Costa S, Bevilacqua D, Calzetti F, Tamassia N, Spina C, et
al. Mature CD10. Blood. 2017;129(10):1343-56.
28. Elghetany MT. Surface antigen changes during normal neutrophilic
development: a critical review. Blood Cells Mol Dis. 2002;28(2):260-74.
29. Wang Y, Wu J, Newton R, Bahaie NS, Long C, Walcheck B. ADAM17
cleaves CD16b (FcγRIIIb) in human neutrophils. Biochim Biophys Acta.
2013;1833(3):680-5.
30. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of
immune response in patients with COVID-19 in Wuhan, China. Clin Infect
Dis. 2020.
31. Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K,
Antoniadou A, Antonakos N, et al. Complex Immune Dysregulation in
COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe.
2020.
32. Barbarin A, Cayssials E, Jacomet F, Nunez NG, Basbous S, Lefèvre L,
et al. Phenotype of NK-Like CD8(+) T Cells with Innate Features in
Humans and Their Relevance in Cancer Diseases. Front Immunol.
2017;8:316.
33. Ohkawa T, Seki S, Dobashi H, Koike Y, Habu Y, Ami K, et al.
Systematic characterization of human CD8+ T cells with natural killer
cell markers in comparison with natural killer cells and normal CD8+ T
cells. Immunology. 2001;103(3):281-90.
34. Addison EG, North J, Bakhsh I, Marden C, Haq S, Al-Sarraj S, et al.
Ligation of CD8alpha on human natural killer cells prevents
activation-induced apoptosis and enhances cytolytic activity.
Immunology. 2005;116(3):354-61.
35. Spits H, Bernink JH, Lanier L. NK cells and type 1 innate lymphoid
cells: partners in host defense. Nat Immunol. 2016;17(7):758-64.
36. Tang F, Quan Y, Xin ZT, Wrammert J, Ma MJ, Lv H, et al. Lack of
peripheral memory B cell responses in recovered patients with severe
acute respiratory syndrome: a six-year follow-up study. J Immunol.
2011;186(12):7264-8.
37. Wrammert J, Onlamoon N, Akondy RS, Perng GC, Polsrila K, Chandele A,
et al. Rapid and massive virus-specific plasmablast responses during
acute dengue virus infection in humans. J Virol. 2012;86(6):2911-8.
38. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M,
et al. Broadly cross-reactive antibodies dominate the human B cell
response against 2009 pandemic H1N1 influenza virus infection. J Exp
Med. 2011;208(1):181-93.
39. chen y, Feng Z, Diao B, Wang R, Wang G, Wang C, et al. The Novel
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly
Decimates Human Spleens and Lymph Nodes. medRxiv.
2020:2020.03.27.20045427.
40. Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, Laumer M,
et al. Isolation and characterization of human antigen-specific TCR
alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood.
2005;105(7):2828-35.
41. Pichler WJ, Wyss-Coray T. T cells as antigen-presenting cells.
Immunol Today. 1994;15(7):312-5.
42. Ren Y, Shu T, Wu D, Mu J, Wang C, Huang M, et al. The ORF3a protein
of SARS-CoV-2 induces apoptosis in cells. Cell Mol Immunol.
2020;17(8):881-3.